生物技术通报 ›› 2016, Vol. 32 ›› Issue (4): 222-227.doi: 10.13560/j.cnki.biotech.bull.1985.2016.04.030

• 研究报告 • 上一篇    下一篇

合成多肽对结核分枝杆菌的胞内抑制作用

陈吉,殷玉和,李玲玲,金浩,唐铭一,吴丛梅   

  1. 长春工业大学化学与生命科学院,长春 130012
  • 收稿日期:2015-07-06 出版日期:2016-04-25 发布日期:2016-04-26
  • 作者简介:陈吉,男,硕士,研究方向:生物工程学;E-mail:415786094@qq.com
  • 基金资助:
    吉林省科技发展计划项目(2008110)

Intracellular Inhibitory Effect of Synthetic Peptide on Mycobacterium tuberculosis

CHEN Ji ,YIN Yu-he, LI Ling-ling ,JIN Hao, TONG Ming-yi, WU Cong-mei   

  1. School of Chemistry and Life Sciences,Changchun University of Technology,Changchun 130012
  • Received:2015-07-06 Published:2016-04-25 Online:2016-04-26

摘要: 评价合成多肽对人白血病单核巨噬细胞THP-1的毒性和对结核分枝杆菌H37Rv的胞内抑菌作用。 通过多肽的不同给药浓度,确定多肽对结核分枝杆菌的最小抑菌浓度(MIC),利用流式细胞术方法和MTT法检测2号肽对细胞THP-1的毒性作用,同时采用CFU方法检测其对H37Rv菌株的胞内抑菌作用。筛选的4条多肽均有抑菌作用,其中2号肽的最小抑菌浓度(MIC)最小,为200 μg/mL。2号肽与细胞THP-1作用时,浓度为1 200 μg/mL时表现出细胞毒性,与 INH细胞毒性无显著差别。对于胞内H37Rv,2号肽抗结核作用具有时间和剂量依赖效应,随给药时间和剂量的增加H37Rv菌落数明显下降。2号肽不仅对巨噬细胞THP-1的毒性小,而且具有较好的抗胞内结核分枝杆菌活性,是一种潜在的抗结核新型药物。

关键词: 合成多肽, 结核杆菌, 巨噬细胞, 胞内抑菌

Abstract: This work is to evaluate the toxicity of the synthetic peptides on mononuclear macrophage THP-1 of human leukemia and the intracellular bacteriostatic effect on Mycobacterium tuberculosis H37Rv. The minimum inhibition concentration(MIC)of the synthetic polypeptide on H37Rv was determined through the different drug concentrations of poly-peptides. Then,the toxic effects of peptide-2 on THP-1 cells were detected using flow cytometry method and MTT method. The colony-forming unit(CFU)method was used for detecting intracellular bacteriostatic effect of peptide-2 on H37Rv. Results were as below:All 4 screened peptides had bacteriostatic effect,the MIC of peptide-2 was 200 mg/mL. When the peptides-2 interacted with THP-1 cells,the cytotoxicity emerged at the concentration of 1200 mg/mL,meaning that there was no significant difference from INH’s cytotoxicity. For intracellular H37Rv,the anti-tuberculosis effects of peptide-2 presented time- and dose- dependent effect,the H37Rv colony count was obviously decreased with the increase of the time and dose. In conclusion,not only has the peptide-2 small toxicity to the macrophage THP-1,but also solid intracellular anti-M. tuberculosis effect,and it can be a new and potential anti-tuberculosis drug.

Key words: synthetic peptide, Mycobacterium tuberculosis, macrophage, intracellular inhibitory